Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

R-51211

Known as: R 51,211, R 51211, R51211 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Itraconazole

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
116 NEW ANTIFUNGAL DRUGS IN TEH PRETERM NEONATE: PHARMACOKINETICS OF KETNAZOLE AND ITRACONAZOLE
The increasing use of invasive procedures, antibiotic and immunosuppressive treatments has caused an increase in candidal… Expand
Is this relevant?
Highly Cited
1989
Highly Cited
1989
Experience with itraconazole in cryptococcosis and aspergillosis.
Cryptococcosis and aspergillosis in immunocompromised patients are extremely difficult clinical conditions to manage and… Expand
Is this relevant?
1988
1988
Itraconazole in the Treatment of Pulmonary Aspergilloma and Chronic Pulmonary Aspergillosis
The new triazole derivative, itraconazole (R51211, Janssen Pharmaceutica) was employed in 8 patients with either pulmonary… Expand
Is this relevant?
1984
1984
R 51211 (itraconazole) therapy of murine cryptococcosis.
A new antifungal triazole, itraconazole (R51211), was compared with ketoconazole in treatment of murine cryptococcosis… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE